Hjem › Tripelnegativ brystkreft › Virginia › Arlington
Kliniske studier for Tripelnegativ brystkreft i Arlington, VA
20 studier for Tripelnegativ brystkreft søker deltakere på steder i og rundt Arlington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
- NEXT Virginia, Fairfax · 11 mi unna
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- NEXT Virginia, Fairfax · 11 mi unna
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RekruttererFase 1/2
- NEXT Virginia, Fairfax · 11 mi unna
Study of AVZO-021 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi unna
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RekruttererFase 3
- Inova Fairfax Hospital, Fairfax · 11 mi unna
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- NEXT Virginia, Fairfax · 11 mi unna
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site, Fairfax · 11 mi unna
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruttererFase 1
- Normunity Investigational Site, Fairfax · 11 mi unna
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Clinical Trial Site, Fairfax · 11 mi unna
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruttererFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi unna
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruttererFase 1
- NEXT Virginia, Fairfax · 11 mi unna
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruttererFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi unna
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- NEXT Virginia, Fairfax · 11 mi unna
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekruttererFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi unna
Study of XB010 in Subjects With Solid Tumors
RekruttererFase 1
- Inova Schar Cancer, Fairfax · 11 mi unna
- NEXT Virginia, Fairfax · 11 mi unna
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruttererFase 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mi unna
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruttererFase 1
- Dren Investigational Site, Fairfax · 11 mi unna
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RekruttererFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi unna
Tripelnegativ brystkreft-studier i andre byer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
- Grand Rapids, MI15 studier
Andre studier i Arlington
- Ikke-småcellet lungekreft104 studier
- Metastatisk kreft53 studier
- Kolorektal kreft52 studier
- Kreft (alle typer)48 studier
- Brystkreft47 studier
- Eggstokkreft46 studier
- Lungekreft41 studier
- Endometriekreft39 studier
- Pankreaskreft33 studier
- Plateepitelcancer i hode og hals26 studier
- Småcellet lungekreft23 studier
- Mavekreft20 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.